First patient has been enrolled to the study in Prague. This makes a total of 53 patients included in the EPISTOP study.

Two more patients were enrolled to EPISTOP in Poland. This means recruitment has reached half of our target!

First patient joined the study in Belgium.

3rd patient joined the study in Vienna this week. Austrian partner in EPISTOP is Medizinische Universitaet Wien represented by prof. Martha Feucht.

Yesterday new patient joined the study in Utrecht, Netherlands.
Congratulations to EPISTOP team from UMC Utrecht supervised by dr. Floor Jansen.